Healthcare in the United States is at a national inflection point. Telehealth, artificial intelligence (AI), and connected health technologies are rapidly transitioning from supplemental tools to core components of care delivery. AI-enabled clinical decision support, remote physiological monitoring, and virtual-first care models are increasingly embedded in routine workflows. Federal agencies such as the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services are actively developing frameworks to guide responsible AI deployment, ensure interoperability, and protect patient safety. At the same time, policymakers are working to avoid a fragmented state-by-state regulatory environment that could slow innovation and limit equitable access to digitally enabled care.
A major policy development is the extension of Medicare telehealth flexibilities through December 31, 2027. Originally expanded during the COVID-19 public health emergency, these provisions include removal of geographic and originating site restrictions, broader practitioner eligibility, continued authorization of audio-only visits, and expanded participation of Rural Health Clinics and Federally Qualified Health Centers as distant sites. This multi-year stability creates an important window for health systems and researchers to generate high-quality real-world evidence on outcomes, cost-effectiveness, and access. Prior analyses have shown that telehealth can maintain clinical quality while improving access for rural and underserved populations, but sustained evaluation will be critical to inform permanent reform [1], [2].
Interstate licensure and reimbursement policy remain key determinants of scalability. The Interstate Medical Licensure Compact has streamlined multi-state physician practice, yet variability in adoption continues to introduce complexity. Meanwhile, legislative proposals in several states signal increased scrutiny of remote patient monitoring reimbursement and AI-enabled mental health tools. As AI becomes further embedded into clinical care pathways, scientific validation, transparency, bias mitigation, and governance safeguards will be essential. The next two years represent a decisive period: telehealth reimbursement is stabilized but not permanent, AI deployment is accelerating while regulatory clarity evolves, and interstate care expansion continues to unfold. The trajectory will ultimately depend on rigorous evidence generation, thoughtful policy design, and sustained commitment to patient-centered digital transformation.
- A. M. Totten et al., “Telehealth: Mapping the Evidence for Patient Outcomes From Systematic Reviews,” Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA, Rep. 16-EHC034-EF, Jun. 2016.
- H. Burstin et al., “Integrating Telehealth and Traditional Care in Chronic Pain Management and Substance Use Disorder Treatment: An Action Agenda for Building the Future State of Hybrid Care,” National Academy of Medicine, Washington, DC, USA, Oct. 2023.
